Original Research
Published on 09 Mar 2022
Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
in Pediatric Oncology
- 7,177 views
- 9 citations
Original Research
Published on 09 Mar 2022
in Pediatric Oncology
Original Research
Published on 09 Mar 2022
in Pediatric Oncology
Original Research
Published on 07 Mar 2022
in Pediatric Oncology
Editorial
Published on 04 Mar 2022
in Pediatric Oncology
Perspective
Published on 25 Feb 2022
in Pediatric Oncology
Review
Published on 21 Feb 2022
in Pediatric Oncology
Original Research
Published on 15 Feb 2022
in Pediatric Oncology
Original Research
Published on 15 Feb 2022
in Pediatric Oncology
Original Research
Published on 12 Jan 2022
in Pediatric Oncology
Original Research
Published on 22 Dec 2021
in Pediatric Oncology
Original Research
Published on 14 Dec 2021
in Pediatric Oncology
Original Research
Published on 14 Dec 2021
in Pediatric Oncology
Review
Published on 10 Dec 2021
in Pediatric Oncology
Original Research
Published on 09 Dec 2021
in Pediatric Oncology
Original Research
Published on 23 Nov 2021
in Pediatric Oncology
Original Research
Published on 23 Nov 2021
in Pediatric Oncology